1-3 of 3
Karl Seeger, PhD, MD
Close
Sort by
Journal Articles

Glucocorticoid Therapy Targets Proliferation, Differentiation and Bcl-2 Dependent Survival Signaling in ALL Blasts.

Peter Rhein, Stefanie Scheid, Richard Ratei, MD, Christian Hagemeier, PhD, MD, Karl Seeger, PhD, MD, Renate Kirschner-Schwabe, PhD, Martin Schrappe, MD, Rainer Spang, PhD, Wolf-Dieter Ludwig, MD, Leonid Karawajew, PhD
Journal: Blood
Blood (2006) 108 (11): 1841.
https://doi.org/10.1182/blood.V108.11.1841.1841
Published: 2006
Journal Articles

Gene Expression in Leukemic Blasts Persisting at Day 8 of Induction Therapy in Childhood ALL Displays a Common Shift towards Terminally Differentiated B Cells and a Cytoreduction-Associated Impairment of the Translational Machinery.

Peter Rhein, Stefanie Scheid, Richard Ratei, MD, Christian Hagemeier, PhD, MD, Karl Seeger, PhD, MD, Renate Kirschner-Schwabe, PhD, Martin Schrappe, MD, Rainer Spang, PhD, Wolf-Dieter Ludwig, MD, Leonid Karawajew, PhD
Journal: Blood
Blood (2005) 106 (11): 537.
https://doi.org/10.1182/blood.V106.11.537.537
Published: 2005
Journal Articles

Prognostic Impact of MRD in the Bone Marrow of Children at First Isolated Extramedullary Relapse of ALL.

Nikola Hanzsch, Cornelia Eckert, PhD, Cecile Acquaviva, PhD, Eva Fronkova, Arend von Stackelberg, MD, Udo zur Stadt, PhD, Andre Schrauder, MD, Jan Trka, PhD, MD, Karl Seeger, PhD, MD, Guenter Henze, MD, Helene Cave, PhD
Journal: Blood
Blood (2004) 104 (11): 1087.
https://doi.org/10.1182/blood.V104.11.1087.1087
Published: 2004